Entrada Therapeutics
Develops medicines that target and treat previously inaccessible intracellular diseases.
H-1B sponsor history — This employer has had H-1B petitions approved by USCIS in the last five fiscal years, per the USCIS H-1B Employer Data Hub. The approval belongs to the employer and is not a commitment to sponsor this role.
biotechpharmaceuticals
Company facts
- Founded
- 2016
- Employees
- 152
- Headquarters
- United States
- Type
- Public
- Listed
- Nasdaq: TRDA
- Subsidiaries
- Entrada Securities Corporation
2 jobs